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Abstract. The generalized phase contrast method is employed as an efficient “phase-only” laser beam-shaping
technique in an optical setup built for catapulting microspheres through simple mucus models. The influence of
the laser power andmucin concentration on the motion of the microspheres is investigated in terms of instant and
average velocities on a 250-μm trajectory, corresponding to the mucus thickness in the human gastrointestinal
tract. Increasing the laser power leads to higher velocities in all the tested samples, while increasing the mucin
concentration leads to significant velocity decrease for similar laser input power. However, velocities of up to
95 μm · s−1 are demonstrated in a 5% mucin simple mucus model using our catapulting system. This study
contributes to understanding and overcoming the challenges of optical manipulation in mucus models. This
paves the way for efficient optical manipulation of three-dimensional-printed light-controlled microtools with
the ability to penetrate the mucus biobarrier for in vitro drug-delivery studies. © The Authors. Published by SPIE under
a Creative Commons Attribution 4.0 Unported License. Distribution or reproduction of this work in whole or in part requires full attribution of the original
publication, including its DOI. [DOI: 10.1117/1.JBO.24.3.035001]
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1 Introduction
Oral delivery of certain biopharmaceuticals would have an out-
standing societal influence, as it should increase patient conve-
nience and compliance. In addition to countless existing
formulations, new highly selective and potent drug candidates
have entered advanced clinical trials in recent years, providing
significant momentum for oral drug delivery. One of the main
challenges in the field is that the intestine secretes mucus, which
constitutes a natural biobarrier rather impermeable to a large
number of compounds.1–3 Hence, thorough understanding of
how biopharmaceuticals interact with and are transported across
mucus and epithelial barriers is of utmost importance.
Mucus is a hydrogel that contains a mixture of mucins as the
principal dry weight component, typically 2% to 5% (w/v), and
low amounts of other proteins and lipids.4 Mucins are high-
molecular weight glycoproteins that can be either secreted or
membrane-bound. Mucus protects the epithelium from patho-
gens, toxins, and endogenous substances such as hydrochloric
acid, pepsin, and other digestive enzymes, while allowing the
exchange of nutrients.5 The heterogeneity of mucus composi-
tions from different species, individuals, and situses is a chal-
lenge for developing appropriate research models of mucus
biobarriers. For example, in humans, the thickness of the
mucus layer throughout the gastrointestinal tract varies between
10 and 250 μm.6 Due to the variable length of the glycoprotein
chains, the mesh-spacing heterogeneity of mucus pores is also
high, varying from 100 nm to several μm.4
Different research studies attempt to mimic mucus composi-
tion to various degrees, with the simplest viable model for
mucus biobarriers being aqueous mucin solutions based on
dehydrated porcine gastric mucin (PGM).7 Rehydrated PGM
dispersions mimic mucus biobarrier properties only to a certain
extent, and their rheological properties do not match those of
native mucus.8 However, in addition to the pore structure and
viscoelastic properties of native mucus, which are important
for size filtering, the mucus mesh also performs interaction fil-
tering on the basis of physicochemical properties9 through, e.g.,
hydrogen bonding, hydrophobic or ionic interactions.10
Although aqueous PGM dispersions are a simplistic model of
the mucus biobarrier, they are widely used due to the availability
of PGM and its physicochemical properties that closely resem-
ble those of human mucins.11,12 PGM-based simple mucus mo-
dels facilitate investigation of the interaction filtering properties
of human mucus biobarriers.
Overcoming the mucus biobarrier for drug delivery has been
attempted with the aid of different vector carriers, such as
mucoadhesive micro- and nanoparticles,13,14 mucus-penetrating
nanoparticles15 and liposomes,16 or cell-penetrating peptides.17
Improving the efficiency of drug carriers for delivery across
mucus biobarriers is generally achieved through controlling
the interaction with mucus by engineering the carriers to
have either mucoadhesive or mucus-penetrating properties.18,19
Chitosan and hyaluronic acid are often used as mucoadhesive
coatings.20 Poly(ethylene glycol) is widely used for “stealth”
surface modification,21–24 and other candidates as mucus-pe-
netrating coatings have recently been reviewed.25 Understanding
the interactions between coated particles and mucus biobarriers
can help design efficient drug carriers for inhalation,26 ocular,20
transnasal,27 vaginal,28 and oral16,29 administration.
Arthur Ashkin’s first report of optical trapping described
how a microsphere hit with a milliwatt power beam will be
“accelerated in the direction of the light.”30 Since then, optical
*Address all correspondence to Jesper Glückstad, E-mail: jesper.gluckstad@
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forces have been employed for actuating microscopic particles
for various applications.31–34 For example, optical tweezers are
particularly useful for single molecule measurements,35–37 while
optical catapulting is more commonly used for particle sorting38
and aerosol analysis.39 Beam shaping allows improved control
over how the optical forces are applied and interact with the
microparticles.40 Whereas actuation typically relies on gradient
forces to attract a particle toward a similarly moving light dis-
tribution, other applications benefit more from optical scattering
forces that effectively push or catapult a particle along a prede-
fined light path.
As a method to extend our understanding of the physico-
chemical interactions occurring within mucus, we demonstrate
the feasibility of optically catapulting microstructures as
means to investigate the biobarrier. Such dynamic experiments
should complement existing methods based on tracking par-
ticles undergoing passive diffusion41,42 and thus allow a more
thorough study of the interaction filtering properties of mucus,
which would then facilitate the screening of different coatings
for improved drug delivery through mucus. We have recently
reported functionalization of three-dimensional (3-D) printed
microstructures for this purpose.43 Finding the best coating
should eventually allow us to develop 3-D printed light-actuated
microtools44–48 with the ability to carry biopharmaceuticals
through the mucus biobarrier for in vitro drug delivery tests.
2 Materials and Methods
2.1 Catapulting Particles with Generalized Phase
Contrast
Our setup for catapulting microspheres benefits from an
extended working distance made possible by using low numeri-
cal aperture (NA) objectives.49–51 Using counter-propagating
catapulting beams, it has also been demonstrated that such low
NA setups can actuate microstructures by transversely translat-
ing and adjusting the relative intensities of the beam pairs.49–51
Low NA objectives allow the light to interact with the sample
environment in a wider, 3-D manner, which will allow us
in the future to perform advanced studies using different
microtools.45,48 Furthermore, this extended geometry facilitates
the extraction of z-depth information through direct side-view
imaging. These features come at the price of typically having
a smaller back aperture in the low NA objective lenses used.
In commonly used holographic optical tweezers,52 a wider
back aperture (higher NA) is necessary to get a wider conjugate
image of the spatial light modulator (SLM) through the aperture.
The generalized phase contrast (GPC) method circumvents
these NA constraints through the use of a “4f” imaging geom-
etry. This means that a localized focused light distribution is si-
tuated at the objective lens’s back aperture, and hence, potential
losses from aperture truncation are minimized. Similar to
diffractive holography, GPC is also an efficient “phase-only”
laser beam-shaping technique.53,54 However, unlike in diffrac-
tive holography, GPC-shaped beams have a well-defined
extended region where the beam intensity is more uniform,
speckle-free, and with well-defined boundaries. The uniform
lateral beam profile of GPC-shaped beams results in a relatively
extended axial profile as the beam propagates, which improves
the optical catapulting of microspheres over long distances.
The GPC method works by transforming an incident
Gaussian beam into desired output shapes, such as a top-hat,
through a direct mapping of the input phase mask patterns.55
To produce a desired output intensity shape, an input phase
mask is visualized at the output plane as an intensity distribution
through common path interference with a synthesized reference
wave (SRW). The SRW is brought about by a phase-contrast
filter (PCF) that usually applies a 180-deg phase shift to the
beam’s lower spatial frequency components. Unlike in the
case of using a Gaussian beam, a microsphere being catapulted
by a GPC-shaped beam receives a uniformly intense radiation
flux over its cross section. A schematic of the GPC light-shaping
method is illustrated in Fig. 1.
When optically catapulting microspheres over an extended
distance, it is desirable to have a beam distribution that remains
relatively localized as it propagates. Awell-known example of a
beam with extended propagation is a Bessel beam.56 However,
in order to efficiently generate a Bessel beam, an axicon phase
distribution must be generated using a freeform refractive opti-
cal element or an extra SLM, which would increase the cost of
the optical setup. Furthermore, the energy in the intense area of
the Bessel beam is only half of the energy available, as the other
half is spread throughout the periphery and accounts for the
“reconstructed light” in subsequent planes. Despite having
a relatively shorter propagation distance where the beam is
localized, compared to a Bessel beam, GPC is more effective in
utilizing the available light, with an energy efficiency of about
Fig. 1 Schematic diagram of the GPC light shaping method.
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84%.55 Furthermore, instead of a freeform refractive optical
element or an additional SLM, GPC requires simple binary
phase masks, which are easier to fabricate.
Figure 2 illustrates different scenarios for how a microsphere
and beam can overlap. The distributions in Figs. 2(a) and 2(b)
represent different magnifications of a typical Gaussian, Airy-
disk or other focal spot distribution characterized by a gradual
intensity roll-off. Figure 2(c) represents a sharply bounded top-
hat that can be generated by GPC. In Fig. 2(c), the light incident
at the microsphere is more evenly distributed compared to that in
Fig. 2(a), while also being more confined to the microsphere
compared to the case in Fig. 2(b). As the beam gets narrower
in Fig. 2(a), this configuration also approaches that of an optical
tweezer that has a shorter manipulation range and will rather
attract instead of catapulting the microsphere. When using
GPC to generate a top-hat as in Fig. 2(c), the setup requires
about a third of the power, compared to the case in Fig. 2(b),
for generating the same intensity level.55 Combined with the re-
latively uniform light intensity distribution on the microsphere,
this efficiency advantage is why GPC was selected as a light-
shaping method in this study.
A typical GPC-generated output beam has a characteristic
top-hat field profile characterized by a sharp change in intensity
at its boundaries. However, as the beam propagates, this profile
changes due to diffraction as shown in Fig. 3.57 Despite this
change in radiation profile, the beam intensity remains relatively
localized when compared to a typical Gaussian or Airy-disk
focal spot generated from a similar optical setup. Hence, a more
consistent amount of scattering force pushes the microsphere as
it traverses in the axial direction. This makes it ideal for cata-
pulting microspheres over a longer distance.47,55,57,58 Although it
is also possible to extend the propagation of Gaussian or Airy-
disk beams by modifying the setup’s magnification, such an
expanded beam would lead to a less efficient system, having
more energy falling outside the microsphere’s cross-sectional
area.
Simulated propagations of a GPC-generated top-hat and
a similarly confined Gaussian beam are shown in Fig. 3. The
simulation emulates practical scenarios wherein all the optical
energy overlaps with the microsphere [as in Figs. 2(a) and 2(a)]
and scaled to match the parameters used in our experiment.
Hence, we chose a GPC disk radius that matches the micro-
sphere’s radius and a Gaussian waist that is one-third of the
microsphere radius (and also one-third of the GPC disk radius).
It can be seen that the GPC beam diverges more slowly than the
narrow Gaussian and therefore provides more consistent force to
a microsphere moving along the axial direction.
The effective force components acting on a spherical particle,
which are typically in the order of piconewtons, were investi-
gated by Rodrigo et al.57 These forces depend on the light inten-
sity distribution, the refractive indices of the host medium and
the particle, and on the fact that the refraction angle is higher at
the edges of the particle than at its center. We are expecting that
the densest light intensity distribution will take place at the
beginning of the microspheres’ movement, where the spatial
distribution is closer to the ideal top-hat. As a microsphere is
moving upward inside the chamber, the light intensity incident
to it is gradually decreasing, which should lead to a deceleration
of the microsphere due to opposing forces, such as gravity and
drag forces.
Fig. 2 Typical configurations at which a microsphere and beam can
overlap. In (a), the majority of the light’s intensity is incident at the
particle, but is significantly lower toward the edges of the particle.
The incident light distribution in (b) is more uniform; however, energy
outside the particle’s boundaries is wasted. In (c), the incident light
intensity is more uniform, while also preventing energy waste. GPC
light shaping (c) provides 3× higher intensity on the particle compared
to (b) for the same beam input power.
Fig. 3 Pseudocolor plot of the xz-plane intensity distribution appearing at z > 0 (arbitrary units) for
a typical focused Gaussian and GPC-generated beam directed toward the positive z-axis.57 The
Gaussian and GPC profiles were set in the simulation so that their energy falls within the same micro-
sphere region. Due to the subsequent focusing with GPC, the color bars are scaled differently to keep
the features visible.
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2.2 Optical Catapulting Experimental Setup
In order to investigate the movement of the microspheres inside
the mucin solutions, the setup in Fig. 4 was constructed. A 1070-
nm laser (IPG Photonics, Massachusetts) shaped by a GPC sys-
tem was used to catapult the microspheres. An LCoS type SLM
(Hamamatsu Photonics, Japan) with 800 × 600 pixels with a
pixel pitch of 20 μm was used to actuate the shaped GPC output
via a “Holo-GPC” configuration.59 Holo-GPC works by multi-
plexing speckle-free GPC top-hats into holographically distri-
buted 3-D locations in the sample volume by utilizing the con-
volution principle.53,60 Hence, having Holo-GPC available is
convenient for addressing multiple microspheres over a wide-
working volume. The measurements in this paper, however,
were performed on individual microspheres, which means
that the method is equally applicable if standard GPC, without
the holographic multiplexing, is used. Hence, despite having an
SLM in the setup, the catapulting experiments reported herein
did not take advantage of this.
The laser was demagnified to have a 1-mm diameter, which
matches a prefabricated GPC light shaper.61 The GPC light
shaper used two Fourier lenses (f ¼ 50 mm) to form a 4f con-
figuration, and had a circular phase mask with a diameter of
0.39 mm, and a PCF with a 38-μm phase-shifting radius.
The Fourier transform of the illuminated phase mask was
expanded onto the SLM by 5× by placing a lens (f ¼ 250 mm)
after the light shaper. The distribution at the SLM was sub-
sequently demagnified onto the back aperture of the objective
lens by 1∕3× using a pair of lenses (f1 ¼ 300 mm and
f2 ¼ 100 mm).
Two objective lenses (f ¼ 3.6 mm, NA ¼ 0.55) were used
to image the GPC disks onto the sample and for the top view and
a third objective lens (f ¼ 45 mm, NA ¼ 0.1) for the side
camera. The resulting disk after the f ¼ 3.6 mm objective
lens had a calculated diameter of ∼17 μm, which closely
matches the 15-μm diameter of the microspheres. The longer
focal length and the working distance of the side-view objective
leave enough clearance from the measurement cuvette and the
top and bottom objectives. Although the relevant data were
obtained through side-view imaging, the top view was necessary
for alignment of the system and ensuring that the beam was
aimed at the microspheres to be catapulted.
2.3 Mucin Preparation
The microspheres to be optically catapulted were suspended in
varying concentrations of PGM (type II, Sigma Aldrich cat. no.
M2378) prepared in HEPES (Sigma-Aldrich Denmark A/S, cat.
no. H0887, pH 7.0-7.6) containing Tween 80 (MP Biomedicals,
California, cat. no. 02103170). A 10-mM HEPES buffer was
prepared by diluting the 1 M HEPES stock in millipore water
(18.2 MΩ · cm at 25°C). For all experiments, the mucin solu-
tions were prepared by adding mucin to the 10-mM HEPES
buffer and allowing it to rehydrate for 20 min at room tempe-
rature under mixing at 300 rpm using an IKA RH basic two
magnetic stirrer. About 0.1% Tween 80 was added to the
samples used in rheology measurements. About 0.1% Tween
80 and 1.5% of 15 μm polybead polystyrene microspheres
(Polysciences Inc., Pennsylvania) were added to the mucin
dispersions for optical catapulting experiments. The refractive
index of the solutions was measured and can be considered
constant, as the difference between millipore water and the 5%
mucin concentration medium is below 1%.
2.4 Rheology Measurements
The effect of mucin concentration on viscosity was evaluated
using an ARES-G2 rheometer (TA Instruments, New Castle,
Delaware), equipped with a peltier plate and truncated cone
(1 deg, 40 mm from TA Instruments, New Castle, Delaware),
and the temperature was set to 21°C. To prevent evaporation
during measurements, a solvent trap cover was used
Fig. 4 Schematic diagram of the setup for catapulting experiments. Illumination for side-view imaging
was achieved with the aid of a portable light source placed near the sample (not included in the diagram).
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(TA Instruments, New Castle, Delaware). Test samples were
carefully pipetted to the center of the peltier plate, and proper
sample distribution and subsequent equilibration were ensured
by a conditioning step with pre-shear set to 10 Pa followed by an
equilibrium step of 5 min at 21°C. Subsequently, a steady state
flow step was carried out by applying a shear rate of 10 to
5000 s−1, conducting three consecutive measurements of 10 s
each, allowing a maximum of 5% variance, collecting four
points per decade. All samples were measured in triplicate
(n ¼ 3). Statistical analysis of the rheological data was done
via a one-way analysis of variance using GraphPad Prism
version 7.0b (GraphPad Software, San Diego, California).
The viscoelastic behavior of the 5% mucin samples was not
characterized. These concentrated samples precipitated during
the conditioning step, leading to an obvious phase separation.
2.5 Optical Catapulting Experiments
For each set of measurements, 15-μm diameter polystyrene
microspheres were placed along with a mucin solution inside
the 250 × 250 μm2 square channel (Fig. 5) from a quartz cuvette
(Hellma GmbH, Germany). The microspheres rapidly sedi-
mented on the bottom of the microchannel. The system was
then aligned to focus on one randomly selected microsphere
for catapulting. The height of the measurement channel was
chosen to match the thickness of the mucus layer in the human
digestive tract.6 The videos were recorded using laser powers (as
set on the laser source) of 0.20, 0.50, 1, 1.50, and 1.80 W and
mucin concentrations of 0.1%, 0.25%, 0.5%, 1%, 3%, and 5%.
This allowed us to investigate the effect on increasing laser
powers on catapulting the microspheres in relation to the diffe-
rent mucin concentrations.
2.6 Microsphere Tracking and Data Analysis
The motion of the microspheres was captured with a point gray
camera at 10 fps. The Manual Tracking plugin designed by
Fabrice P. Cordelières for the ImageJ software62 was used for
tracking the microspheres for all the experiments. The accuracy
of the tracking is limited by the pixel size of the recorded videos
to ∼0.1 μm. The microspheres were tracked from the first frame
in which they rise above the lower cuvette wall until the last
frame just before reaching the upper cuvette wall (a distance
corresponding to ∼250 μm, as defined by the chamber height).
The “instantaneous” velocities of the microspheres (for the
shortest observable time intervals of 0.1 s, as determined by
the frame rate) were computed in the software and either
used as such (denoted as instant velocities) or averaged for the
entire trajectory (denoted as average velocities). Recordings
where a second microsphere interfered with the catapulting
were excluded from the analysis. The trajectories of 10 micro-
spheres from five different samples were analyzed for every
mucin concentration and catapulting laser power.
The motion of microspheres in 3% mucin using 0.2 W input
laser power was extremely slow, which would cause significant
errors in tracking due to subpixel size displacements in between
consecutive frames, and thus it was excluded from the data
analysis. In 5% mucin, an input laser power of 0.2 W was
not sufficient to push the microspheres upward.
The sensitivity of the system in terms of its ability to respond
to perturbations caused by the presence of mucin is given by the
slope of the linear fit passing through the origin in the velocity
versus laser power plots. This parameter was calculated from
both the average and maximum instant velocities and is given
in μm · s−1 · W−1).
3 Results and Discussion
3.1 Viscoelastic Behavior of Mucin Samples
As it can be seen in Fig. 6, the viscoelastic behavior of samples
containing low concentrations of mucin (up to 0.25%) is very
similar to that of buffer (no statistical differences). This indicates
that in these samples, the glycoprotein chains do not form
a detectable network of secondary interactions, most likely due
to the too large distances between the mucin fragments.
The samples with mucin concentrations between 0.5% and
3% behave in similar manner and are characterized by increased
viscosity and a changed viscoelastic behavior (shear thinning)
compared to buffer. This indicates the formation of a viscoelas-
tic network. Based on these results, the critical concentration
for the formation of a viscoelastic network in our experimental
conditions should be between 0.25% and 0.5% mucin.
3.2 Catapulting in Water
In order to ensure that our setup allows reproducible measure-
ments, we initially conducted a series of experiments using a
“blank” sample without mucin, which contained millipore
Fig. 5 Bright field image of a microsphere being catapulted inside
millipore water taken with the side-view camera. a: Measurement
cuvette containing microspheres mixed in mucin dispersion; b: lower
cuvette wall; c: upper cuvette wall; d: microsphere being catapulted;
e: other microspheres lying on the bottom of the measurement
cuvette. The microspheres have a diameter of 15 μm. The visible top
(c) and bottom (b) inner walls of the cuvette are 250-μm apart.
Fig. 6 Rheological characterization of samples (n ¼ 3) containing
different mucin concentrations.
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water, 0.1% Tween 80 and 1.5% of 15 μm polystyrene
microspheres.
The instantaneous, average, and maximum velocities of the
microspheres in water are shown in Fig. 7. The system is opti-
mized such that the GPC disks are formed at the lower wall of
the measurement chamber, where the microspheres are also
lying, and thus provides an optimal overlap with the GPC disks
in the beginning of the microsphere trajectories. However, due
to the axially changing intensity distribution of GPC-shaped
beams (Fig. 3), there is an initial “slowness” in the microsphere
motion and the highest velocities are achieved a fraction of a
second after the microspheres start being pushed by the laser
beam, after the microsphere goes past the more intense region
of the beam. The local intensity maxima before the broad intense
region (Fig. 3) could also be causing weak gradient forces that
initially attract the microsphere. As the microspheres move ver-
tically through the measurement chamber, their speed is decrea-
sing sensibly, which is to be expected, as described in Sec. 2.1.
This decrease as the microspheres are catapulted further from
the image plane of the GPC beam is more obvious at high
laser powers (1.5 and 1.8 W), as it can be observed in Fig. 7(a).
At low laser powers (0.2 and 0.5 W), the frame-to-frame dis-
placement of the microspheres is of only several pixels, which
causes the calculated instant velocity signal to be noisy and
makes the velocity decrease less observable.
A comparison between different input powers for catapulting
in water is shown in Video 1. The microsphere displacement
0.5 s after turning on the laser beam can be seen in Fig. 8(a).
3.3 Catapulting in Mucin
In order to understand how the presence of short mucin glyco-
protein chains affects the ability to catapult microspheres in our
system, we investigated aqueous dispersions containing 0.1% to
5% mucin. Among these, the 3% and 5% aqueous mucin dis-
persions can be considered simple mucus models due to the
similarity with the 2% to 5% mucin content of native mucus.
A comparison between different input powers for catapulting
in 1% mucin is shown in Video 2. The microsphere displace-
ment 1 s after turning on the laser beam can be seen in
Fig. 8(b).
Fig. 7 Tracking results in water samples containing Tween 80 (n ¼ 10): (a) instant velocities as a func-
tion of time for different laser powers and (b) maximum and average velocities as a function of laser
power.
Fig. 8 Comparison of optical catapulting of polystyrene microspheres using different input laser powers in
(a) water (Video 1) and (b) 1%mucin (Video 2). The frames shown correspond to (a) 0.5 s and (b) 1 s after
turning on the laser beam for catapulting. (Video 1, MP4, 0.5 MB[URL: https://doi.org/10.1117/1.JBO.24.3
.035001.1].; Video 2, MP4, 2.3 MB[URL: https://doi.org/10.1117/1.JBO.24.3.035001.2].).
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The experimental results obtained using different laser
powers in aqueous mucin dispersions with concentrations up
to 5% are presented in Fig. 9. Each experimental data point
was calculated by averaging the velocity of 10 microspheres.
The average values, including standard deviations, are given
in Sec. 5.
As it can be seen in Fig. 9, increasing the laser power leads to
a velocity increase for all tested samples. On the other hand, the
average velocities of the microspheres decrease as the mucin
concentration increases. This is an anticipated behavior due
to the biobarrier properties of mucus, which the mucin disper-
sions replicate to some extent. The velocity decrease can be
attributed to a combined effect of altered light propagation in
mucin dispersions and to physicochemical interactions between
the polystyrene microspheres and the simple mucus model.
Polystyrene surfaces are slightly charged and hydrophobic,63
with loose polymer chains present at the interface.64 Thus, it
is to be expected that the polystyrene microspheres employed
in our study can lead to hydrophobic interactions65 with the
mucin fragments.
The sensitivity of the system (calculated from both instant
and average velocities) decreases exponentially as the mucin
concentration increases, as shown in Fig. 10. This shows that
the addition of mucin glycoprotein chains in low concentrations
(0.1% to 1%) significantly changes the behavior of the micro-
spheres, which can be partly attributed to the physicochemical
interactions between the polystyrene microspheres and the
mucin fragments. The addition of low amounts of mucin
does not change the viscoelastic behavior, but it can already
lead to hydrophobic interactions between the microspheres and
the sample. Beyond 0.5% mucin, the glycoprotein fragments
assemble in a viscoelastic network. This can explain why further
increasing the mucin concentration has a lower effect on the
sensitivity.
4 Conclusions
To the best of our knowledge, this work is the first to study
the laser catapulting of microspheres as a means to investigate
a model mucus biobarrier. The influence of the laser power
and mucin concentration on the microsphere motion was inves-
tigated and analyzed. To ensure catapulting over a relatively
long (250 μm) distance, similar to the thickness of mucus in
the human digestive tract, we used the GPC light-shaping
method, which has been previously tested in extended geo-
metries. The setup was developed to allow beam shaping using
Holo-GPC, which can be used in future studies for simultane-
ously catapulting multiple microspheres.
The setup demonstrated optical manipulation of the micro-
spheres through solutions with high mucin concentrations
using input laser powers as low as 0.5 W. As expected, increa-
sing the mucin concentration led to a decrease in microsphere
velocity, while increasing the laser power for a given mucin so-
lution lead to an increase in microsphere velocities. Our system
for optical catapulting allows us to push polystyrene micro-
spheres through the simple mucus model investigated. In the
future, particles with different shapes and surface chemistry
can be compared in this setup to gather information about
the physicochemical interactions between such particles and
their environment. This suggested approach can complement
existing methods that study such interactions by offering the
user control over the dynamic testing conditions through simply
adjusting the input laser power.
Understanding optical manipulation in mucus models is vital
for future biomedical applications of light-controlled micro-
particles for in vitro drug delivery tests. In order to attempt
drug delivery through mucus biobarriers using light-actuated
microtools, optical manipulation needs to be optimized to
accommodate the requirements of both light-control and hand-
ling biological samples. Precise optical manipulation, can be
better achieved using increased laser irradiation, but there is
an inherent need to minimize the applied laser intensity to
avoid photodamage of biological samples. Our findings will
support further investigation of overcoming the mucus biobar-
rier for biopharmaceutical applications using light-controlled
particles with different surface properties and light-actuated
microtools.
5 Appendix
Table 1 shows the average values (n=10), including standard
deviations, of microspheres catapulted in simple mucus models
with different mucin concentrations using different input laser
powers.
Fig. 9 Average velocities (n ¼ 10) at different laser powers and diffe-
rent mucin concentrations. “B” is a blank sample containing 0.1%
Tween 80 in millipore water.
Fig. 10 Sensitivity decrease of the system at increasing mucin
concentrations. The sensitivity values were calculated from both the
average and maximum velocities versus laser power plots.
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